The sale of Omnicare’s LTC pharmacy business is not just another healthcare transaction. It is a clear signal that the economic and operational realities facing long-term care (LTC) pharmacy are shifting in ways that affect every type of provider in the market, big or small.
On May 13, 2026, the U.S. Bankruptcy Court for the Northern District of Texas approved the $250 million sale of Omnicare — a subsidiary of CVS Health – to GenieRx Holdings LLC, a joint partnership between private investment firm Milrose Capital LLC and healthcare investment and management firm Integro Asset Management LLC, operating as Integro Healthcare Services. The transaction is expected to close later in 2026, pending regulatory approval, with Omnicare continuing to serve its clients through the transition period. Read More >
